---
title: "Raphael Pharmaceutical Inc. (RAPH.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RAPH.US.md"
symbol: "RAPH.US"
name: "Raphael Pharmaceutical Inc."
industry: "Biotechnology"
---

# Raphael Pharmaceutical Inc. (RAPH.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.raphaelpharmaceutical.com](https://www.raphaelpharmaceutical.com) |

## Company Profile

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to dev...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -20.16 | 513/605 | - | - | - |
| PB | -22.35 | 548/605 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/RAPH.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RAPH.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RAPH.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.